Penicillamine
Term · Oncology and biomedicine · MLC-T-ONC-006476
A drug that removes copper from the body and is used to treat diseases in which there is an excess of copper. It is also being studied as a possible angiogenesis inhibitor in the treatment of brain tumors.
A beta dimethyl analog of the amino acid cysteine. As a degradation product of penicillin antibiotics, penicillamine chelates with heavy metals and increases their urinary excretion. Possessing antineoplastic properties, penicillamine induces apoptosis by a p53-mediated mechanism and inhibits angiogenesis by chelating with copper, a cofactor for angiogenesis.
| Identifier | MLC-T-ONC-006476 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | D-mercaptovaline; D-Penicillamine; Depamine |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-006476",
"term": "Penicillamine",
"field": "Oncology and biomedicine",
"definitions": [
"A drug that removes copper from the body and is used to treat diseases in which there is an excess of copper. It is also being studied as a possible angiogenesis inhibitor in the treatment of brain tumors.",
"A beta dimethyl analog of the amino acid cysteine. As a degradation product of penicillin antibiotics, penicillamine chelates with heavy metals and increases their urinary excretion. Possessing antineoplastic properties, penicillamine induces apoptosis by a p53-mediated mechanism and inhibits angiogenesis by chelating with copper, a cofactor for angiogenesis."
],
"synonyms": [
"D-mercaptovaline",
"D-Penicillamine",
"Depamine"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/penicillamine/"
}
Record 12,905 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.